Long-acting injectable antipsychotics provide better outcomes in bipolar disorder and older schizophrenia patients
A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has found that long-acting injectable (LAI) antipsychotics provide better treatment outcomes than oral antipsychotic medications for patients 65 and older with schizophrenia.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Nursing home beds are becoming more scarce
-
Air pollution and cardiovascular disease: Mitochondria may be the missing link
-
New polymer could enable gastrointestinal transit monitoring without ionizing radiation
-
How stores choose what to put on their shelves — like, say, Planet Money's board game
-
IBD not linked to risk of hypertensive disorders of pregnancy overall
-
Landmark trial evaluates chemotherapy benefit in high-risk early-stage breast cancer
-
FDA panel narrowly backs multi-cancer blood test despite doubts it works
-
Blood proteins shift during Alzheimer's treatment and may help monitor the effects of the medication